CCR9 modulator (SunRock Biopharma)

N/A

Report date: 2025/06/11 10:52:25

Base Information

Drug NameCCR9 modulator (SunRock Biopharma)
Drug Alias NameSRB-1SRB-2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionC-C chemokine receptor type 9 antagonistsImmunomodulators
TargetsC-C chemokine receptor type 9
Therapy Area/IndicationsPancreatic NeoplasmsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentro Nacional de Biotecnología
China Registration ClassN/A

Develop Information

Active CompaniesSunRock Biopharma SL
Inactive CompaniesCentro Nacional de Biotecnología
Active IndicationsPancreatic NeoplasmsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A